1. Pharmacokinetics of Pomalidomide in a Patient Receiving Hemodialysis Using a High- Cutoff Filter 
Kim Dao, MD, Haithem Chtioui, MD, Yimin Lu, MD, Cody J. Peer, MS, PhD, William D. Figg, PharmD, FCP, Menno Pruijm, MD, Thierry Buclin, MD, Sébastien Kissling, MD 
American Journal of Kidney Diseases 
Volume 69, Issue 4, Pages (April 2017)
DOI: /j.ajkd
Copyright © 2016 National Kidney Foundation, Inc. Terms and Conditions

2. Figure 1
Predicted (continuous line) and measured (open circles) pomalidomide concentrations over time. HCO dialysis sessions are indicated by grey horizontal bars; pomalidomide doses (2mg), by open triangles. Predicted concentrations (with 2mg/d dosage) in the absence of dialysis denoted by dotted line.
American Journal of Kidney Diseases  , DOI: ( /j.ajkd )
Copyright © 2016 National Kidney Foundation, Inc. Terms and Conditions